Citing an analysis of four hospital bills by drug-price regulator National Pharmaceutical Pricing Authority (NPPA), the SJM said it provided clear evidence of exploitation of patients by the private hospitals.
The analysis showed that 40.85 per cent of the charges were for medicines, consumables and devices, and 15.56 per cent was for diagnostic services, the SJM said. In other words, these two constituted 56.41 per cent of the total cost, it said.
"SJM demands an urgent intervention of the government to put an end to this shameless profiteering at the cost of peoples' lives," SJM co-convener Ashwani Mahajan said in a statement.
"SJM urges the government to fix the charges of procedures, and fixed cost of treatment such as diagnostic services, consultation charges and equipment costs," Mahajan added.
He further said this could be done using the powers under the concurrent list, which empowered the government to legislate on price control and supply of essential goods and services.
SJM also demanded that the Competition Commission of India (CCI) carry out an investigation of anti-competitive practices followed by hospitals in the pricing of medicines and medical devices.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
